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Abstract. 
 
The synaptic vesicle protein synaptotagmin I 
has been proposed to serve as a Ca
 
2
 
1
 
 sensor for rapid 
exocytosis. Synaptotagmin spans the vesicle membrane 
once and possesses a large cytoplasmic domain that 
contains two C2 domains, C2A and C2B. Multiple Ca
 
2
 
1
 
 
ions bind to the membrane proximal C2A domain. 
However, it is not known whether the C2B domain also 
functions as a Ca
 
2
 
1
 
-sensing module. Here, we report 
that Ca
 
2
 
1
 
 drives conformational changes in the C2B do-
main of synaptotagmin and triggers the homo- and het-
ero-oligomerization of multiple isoforms of the protein. 
These effects of Ca
 
2
 
1
 
 are mediated by a set of con-
served acidic Ca
 
2
 
1
 
 ligands within C2B; neutralization of 
these residues results in constitutive clustering activity. 
We addressed the function of oligomerization using a 
dominant negative approach. Two distinct reagents that 
block synaptotagmin clustering potently inhibited se-
cretion from semi-intact PC12 cells. Together, these 
data indicate that the Ca
 
2
 
1
 
-driven clustering of the C2B 
domain of synaptotagmin is an essential step in excita-
tion-secretion coupling. We propose that clustering may 
regulate the opening or dilation of the exocytotic fusion 
pore.
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2
 
1
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Introduction
 
C2 domains are conserved motifs found in nearly a hun-
dred proteins that function in cellular processes ranging
from membrane traffic to blood coagulation. These do-
mains are composed of 
 
z
 
130 amino acids and fold into
compact eight-stranded distinct 
 
b
 
-sandwich structures.
Three flexible loops protrude from the tip of the domain.
In some cases, two of these loops form a pocket that medi-
ates the binding of Ca
 
2
 
1 
 
and other divalent cations (Sutton
and Sprang, 1995; Sutton et al., 1995, 1999; Grobler et al.,
1996; Perisic et al., 1998; Ubach et al., 1998a,b; Pratt et al.,
1999; Macedo-Ribeiro et al., 1999). Ca
 
2
 
1 
 
binding regulates
the interaction of some C2 domains with target molecules
including lipids and proteins, while other C2 domains do
not appear to bind Ca
 
2
 
1
 
. Thus, the emerging view is that
C2 domains are not necessarily Ca
 
2
 
1 
 
-binding motifs, but
rather function as modules that interact with a broad
range of target molecules (reviewed by Nalefski and
Falke, 1996). In most cases, the biochemical and physio-
logical functions of C2 domains remain to be defined.
Synaptotagmin was the first integral membrane protein
discovered that harbored C2 domains (Matthew et al.,
1981; Perin et al., 1990). This protein is localized to synap-
tic vesicles and large dense core secretory vesicles (Mat-
thew et al., 1981). It spans the vesicle membrane once and
has a short luminal domain and a large cytoplasmic region
largely comprised of two C2 domains, designated C2A and
C2B. These tandem C2 domains prompted biochemical
studies, which demonstrated that synaptotagmin I is a
Ca
 
2
 
1
 
-binding protein (Brose et al., 1992; Davletov and
Südhof, 1993; Chapman and Jahn, 1994). Subsequent gene
disruption studies in mice, 
 
Caenorhabditis elegans
 
, and
 
Drosophila
 
 demonstrated that synaptotagmin I is essential
for rapid and synchronous Ca
 
2
 
1
 
-triggered release of neu-
rotransmitters (Littleton et al., 1993; Nonet et al., 1993;
DiAntonio and Schwarz, 1994; Geppert et al., 1994; Little-
ton et al., 1994), suggesting that synaptotagmin I may func-
tion as a Ca
 
2
 
1
 
 sensor that regulates neuronal exocytosis
(Katz, 1969).
Seven isoforms of synaptotagmin have been identified
in the 
 
Drosophila
 
 genome (Littleton et al., 1999; Littleton,
J.T., and E.R. Chapman, unpublished observations), indi-
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cating that the vertebrate gene family may be much larger
than the current set of 12 isoforms. Furthermore, alterna-
tively spliced forms of synaptotagmin have been identified
that lack the transmembrane anchor (Fukuda and Miko-
shiba, 1999). These findings suggest that synaptotagmins
may have widespread functions in intracellular membrane
traffic.
A key to understanding the physiological function of
synaptotagmin is to understand the biochemical properties
of its C2 domains. The C2A domain of synaptotagmin I
binds multiple Ca
 
2
 
1
 
 ions (Sutton et al., 1995; Ubach et al.,
1998b), and becomes partially inserted into membranes
that contain anionic phospholipids (Chapman and Davis,
1998; Davis et al., 1999; Bai et al., 2000). Equilibrium and
kinetic Ca
 
2
 
1
 
 binding properties of C2A are consistent with
the Ca
 
2
 
1
 
 requirement and speed of secretion (Davis et al.,
1999).
The C2A domain is connected to C2B by a short tether
and the tandem C2 domains cooperate to form complexes
with components of the soluble 
 
N
 
-ethyl maleimide-sensi-
tive factor attachment protein receptor (SNARE)
 
1
 
 com-
plex (Chapman et al., 1995, 1996; Davis et al., 1999; Ge-
rona et al., 2000). This complex is composed of the target
SNAREs (t-SNAREs) syntaxin and SNAP-25 and the ves-
icle SNARE synaptobrevin (Söllner et al., 1993); assembly
of the complex is necessary (Littleton et al., 1998; Chen et
al., 1999) and may be sufficient (Weber et al., 1998) for
exocytotic membrane fusion. Synaptotagmin forms direct
contacts with both t-SNAREs at all stages of the SNARE
complex assembly (data not shown; Chapman et al., 1995;
Schiavo et al., 1997; Davis et al., 1999; Gerona et al., 2000)
and can bind SNAREs and interact with membranes at the
same time (Davis et al., 1999). These interactions suggest
that synaptotagmin may regulate SNARE-mediated mem-
brane fusion by modulating the conformation and/or as-
sembly of SNARE complexes.
The interactions of synaptotagmin with SNAREs and
anionic phospholipids are regulated by Ca
 
2
 
1
 
 ligands that
reside within C2A (Bai et al., 2000). Here, we address the
question of whether and how the C2B domain of synap-
totagmin functions as a Ca
 
2
 
1
 
-sensing module during exo-
cytosis. This question was prompted by the finding that
mutations within the C2B domain of 
 
Drosophila
 
 synap-
totagmin impair excitation-secretion coupling (DiAnto-
nio and Schwarz, 1994; Littleton et al., 1993, 1994). A
number of C2B–effector interactions have been identified
including the following: AP-2 (Zhang et al., 1994; Jorgen-
son et al., 1995), SV2 (Schivell et al., 1996), 
 
b
 
-SNAP (Schi-
avo et al., 1995), Ca
 
2
 
1
 
 channels (Kim and Catterall, 1997;
Sheng et al., 1997), inositol polyphosphates (Fukuda et al.,
1995) and, finally, homo-oligomerization (Chapman et al.,
1996; Sugita et al., 1996). Of these interactions, only oligo-
merization was promoted by Ca
 
2
 
1
 
.
While C2B was implicated in mediating Ca
 
2
 
1
 
-triggered
synaptotagmin clustering, this domain has not been di-
rectly shown to sense Ca
 
2
 
1
 
 or transduce Ca
 
2
 
1
 
 binding to
clustering activity. Here, we report that the C2B domains
of multiple synaptotagmin isoforms undergo Ca
 
2
 
1
 
-driven
conformational changes and can homo- and hetero-oligo-
 
merize with one another. We have characterized the struc-
tural requirements for these Ca
 
2
 
1
 
 effects, and have applied
a dominant negative approach to determine the role of
Ca
 
2
 
1
 
-triggered synaptotagmin clustering in Ca
 
2
 
1
 
-regu-
lated exocytosis. Our findings indicate that Ca
 
2
 
1
 
-driven
clustering of synaptotagmin constitutes a novel step in ex-
citation-secretion coupling.
 
Materials and Methods
 
Recombinant Proteins 
 
cDNA encoding rat synaptotagmin Ia (Perin et al., 1990) and Ib (Osborne
et al., 1999) were provided by T.C. Südhof (University of Texas South-
western Medical Center, Dallas, TX) and G. Schiavo (Imperial Cancer
Research Fund, London, UK; Osborne et al., 1999), respectively. pGEX
expression vectors to produce the cytoplasmic domains of synaptotagmins
II–XIII (Li et al., 1995) were also provided by T.C. Südhof. pGEX expres-
sion vectors to produce the C2B domains of mouse synaptotagmins III
and IV (Fukuda et al., 1995) were provided by M. Fukuda (Brain Science
Institute, Ibaraki, Japan) and the C2B domains for rat synaptotagmins
V–VIII were generated by PCR and were subcloned via BamHI and
EcoRI sites into pGEX-2T. pGEX expression vectors to produce the C2A
and C2B domain of rabphilin (Ubach et al., 1998a) were provided by J.
Rizo (University of Texas Southwestern Medical Center, Dallas, TX).
The cytoplasmic (residues 96–421) and C2A domains (residues 96–265)
of synaptotagmin Ia and Ib (see Fig. 1) were prepared as previously de-
scribed (Chapman et al., 1995, 1996). A new C2B domain (residues 248–
421) was generated from the synaptotagmin Ib sequence reported by Os-
borne et al. (1999) and subcloned into pGEX-2T as previously described
(Chapman et al., 1996). A series of point mutations (see Fig. 3) were gen-
erated by PCR and also expressed as GST fusion proteins. Soluble synap-
totagmin fragments were prepared by thrombin cleavage of GST fusion
proteins using thrombin (Chapman et al., 1996). His
 
6
 
-synprint (Sheng et
al., 1997) was prepared as previously described (Chapman et al., 1998).
 
Binding Assays 
 
All recombinant protein binding assays were carried out by immobilizing
one protein on glutathione-Sepharose beads. Immobilized fusion proteins
were incubated with soluble binding partners for 1–2 h at 4
 
8
 
C in TBS (20
mM Tris and 150 mM NaCl) plus 0.5% Triton X-100 with either 2 mM
EGTA or 1 mM free Ca
 
2
 
1
 
, Mg
 
2
 
1
 
, Ba
 
2
 
1
 
, or Sr
 
2
 
1
 
. Beads were washed three
times in binding buffer. Proteins were solubilized by boiling in SDS sam-
ple buffer and subjected to SDS-PAGE. In most cases, proteins were visu-
alized by staining with Coomassie blue. However, synprint binding was
detected by immunoblotting using a monoclonal antibody directed against
the T7-tag (Novagen).
All GST pull-down assays using brain detergent extracts were carried
out as described (Chapman et al., 1998). Bound proteins were detected by
immunoblotting using mouse monoclonal antibodies directed against the
luminal domain of synaptotagmin I (604.4) and 
 
a
 
/
 
b
 
-SNAP (77.1; this anti-
body recognizes 
 
a
 
 and 
 
b
 
 SNAP equally well) that were kindly provided by
S. Engers and R. Jahn (Max Planck Institute for Biophysical Chemistry,
Goettingen, Germany). The antibody directed against 
 
a
 
-adaptin (100.2)
was obtained from Sigma-Aldrich.
All binding assays were carried out at least four times and representa-
tive experiments are shown in the figures.
 
Limited Proteolysis 
 
Immobilized GST fusion proteins were incubated for 1 h at room temper-
ature in TBS with the indicated concentrations of chymotrypsin or trypsin
in the presence of either 2 mM EGTA or 1 mM free Ca
 
2
 
1
 
. Reactions were
stopped by boiling in SDS sample buffer and samples were subjected to
SDS-PAGE. Proteolytic fragments were visualized by staining with Coo-
massie blue, and samples were analyzed for the differential accumulation
of proteolytic fragments in EGTA versus Ca
 
2
 
1
 
. Ca
 
2
 
1
 
 dose–response as-
says were carried out in a similar manner using a fixed protease concentra-
tion. Free [Ca
 
2
 
1
 
] was determined using a Ca
 
2
 
1
 
 electrode as previously de-
scribed (Davis et al., 1999). Accumulation of a fragment that is selectively
protected in the presence of Ca
 
2
 
1
 
 was monitored by staining SDS-PAGE
 
1
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N
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gels with Coomassie blue, and the band of interest was quantified by den-
sitometry. Pixel intensities were plotted as a function of free [Ca
 
2
 
1
 
].
 
Norepinephrine Release Assays 
 
Norepinephrine release from permeable PC12 cells was carried out as pre-
viously described (Hay and Martin, 1992; Hay et al., 1995).
 
Results
 
Two Forms of Synaptotagmin I with Distinct 
Oligomerization Properties
 
The discovery that Ca
 
2
 
1
 
 triggers the oligomerization of
synaptotagmin raises the question of whether and how this
interaction functions to regulate exo- and/or endocytosis.
Efforts to address this issue were hampered by the in-
ability to generate recombinant rat synaptotagmin I that
possessed Ca
 
2
 
1
 
-triggered clustering activity. In previous
studies, the recombinant protein was able to serve as an
acceptor for the Ca
 
2
 
1
 
-triggered binding of native synap-
totagmin I from brain detergent extracts, but was not able
to homo-oligomerize in response to Ca
 
2
 
1
 
 (Chapman et al.,
1996; Fig. 1 B). Thus, we could not assay for direct C2B–
C2B interactions. We then explored the possibility that
this loss of function was determined by the primary se-
quence of the protein. This possibility was prompted by
the independent cloning of a synaptotagmin I cDNA (Os-
borne et al., 1999). The cytoplasmic domain of this clone
was reported to differ from the original clone (Perin et al.,
1990). We have resequenced these two cDNAs, and found
that they vary by a single amino acid at position 374 (re-
garding the other two reported differences: one was not
detected in our sequence analysis and one corresponds to
a sequence error in the original report).
For simplicity, we refer to the original cDNA as Ia
(Perin et al., 1990) and the second version as Ib (Osborne
et al., 1999). Synaptotagmin Ib harbors a glycine at posi-
tion 374 (G374), which is precisely conserved among all
synaptotagmins; the lone exception is synaptotagmin Ia,
which harbors an aspartate at this position (D374; Fig. 1
A). To determine whether the presence of D374 underlies
the loss of Ca
 
2
 
1
 
-triggered self-association activity of syn-
aptotagmin Ia, we incubated soluble cytoplasmic domains
of synaptotagmin Ia or Ib with their counterparts that had
been immobilized as GST fusion proteins on glutathione-
Sepharose beads. As shown in Fig. 1 B, synaptotagmin
Ia failed to oligomerize in response to Ca
 
2
 
1
 
; only trace
levels of binding were observed in EGTA and Ca
 
2
 
1
 
. In
Figure 1. Glycine 374 in the
C2B domain of synaptotag-
min I plays a critical role in
Ca21-triggered oligomeriza-
tion. (A) Alignment of the
C2B domains of distinct syn-
aptotagmins. Putative acidic
Ca21 ligands are rendered in
shaded boxes and numbered
in bold type at the bottom of
the alignment. These resi-
dues were identified as Ca21
ligands in the crystal struc-
ture of the C2A domain of
synaptotagmin (Sutton et al.,
1995), and are conserved
among the C2B domains of
multiple synaptotagmin iso-
forms. Two lysine residues
that are critical for oligomer-
ization (Chapman et al.,
1998) are boxed and indi-
cated with closed arrow-
heads. The last amino acid in
the alignment is indicated
with a black background and
an open arrowhead. This res-
idue is a glycine in all synap-
totagmins from all species
with the exception of synap-
totagmin Ia. See Results for details. (B) Ca21 triggers the oligomerization of synaptotagmin Ib but not Ia. 10 mg GST or GST-synap-
totagmin Ia or Ib was immobilized on glutathione-Sepharose beads. Beads were incubated with 0.75 mM of soluble synaptotagmin Ia or
Ib for 1.5 h in 150 ml TBS plus 0.5% Triton X-100 and either 2 mM EGTA (2Ca21) or 1 mM Ca21 (1Ca21). Beads were washed three
times with binding buffer and boiled in SDS sample buffer. 7% of the soluble synaptotagmin from the binding assay (left two lanes) and
40% of the bound material (remaining lanes) were subjected to SDS-PAGE and visualized by staining with Coomassie blue. Synap-
totagmin Ib, harboring G374, oligomerized in response to Ca21. Synaptotagmin Ia, harboring D374, exhibited only trace levels of clus-
tering activity (indicated by the asterisk). Stg, cytoplasmic domain of synaptotagmin I. (C) Cation selectivity for recombinant synap-
totagmin oligomerization. Synaptotagmin Ib oligomerization assays were carried out as described in B, in the presence of 2 mM EGTA,
1 mM Ca21, 1 mM Mg21, 1 mM Ba21, or 1 mM Sr21. A representative experiment is shown in the upper panel; the level of binding was
quantified by densitometry of a Coomassie-stained gel, and is plotted in the lower panel of the figure. 
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marked contrast, soluble synaptotagmin Ib exhibited a
pronounced binding to immobilized synaptotagmin Ib in
response to Ca
 
2
 
1
 
. This effect is selective for Ca
 
2
 
1
 
: Mg
 
2
 
1
 
failed to trigger binding, and Ba
 
2
 
1
 
 and Sr
 
2
 
1
 
 were less po-
tent than Ca
 
2
 
1
 
 in driving clustering (Fig. 1 C). These data
demonstrate that the inability of synaptotagmin Ia to clus-
ter in response to Ca
 
2
 
1
 
 is due to the presence of an aspar-
tate residue at position 374. The precise conservation of
the glycine residue at this position, with the lone exception
of synaptotagmin Ia, suggests that multiple synaptotag-
mins may exhibit clustering activity, as borne out by data
described below.
We have confirmed the expression of both the G- and
D374 forms by sequencing synaptotagmin cDNA from a
variety of cDNA libraries (data not shown). At present, it
is unclear how the D374 form of synaptotagmin arises; the
genomic sequence of the rat clone has not been reported.
Future studies are required to determine whether varia-
tion occurs at position 374 via RNA editing or alternative
splicing, and whether seizure activity or other factors can
influence the relative levels of the Ia and Ib messages.
We reiterate that while synaptotagmin Ia cannot oligo-
merize with itself, it can serve as an acceptor for the clus-
tering activity of native synaptotagmin (Chapman et al.,
1996; Sugita et al., 1996). Thus, clustering appears to in-
volve at least two separable determinants or domains, and
synaptotagmin Ia is only defective in one of these do-
mains.
 
Mechanism of Ca
 
2
 
1
 
-triggered
Synaptotagmin Oligomerization
 
The finding that synaptotagmin Ib exhibits robust Ca
 
2
 
1
 
-
triggered clustering activity made it possible to examine
the structural features that drive oligomerization. Our first
goal was to determine whether the C2B domain was nec-
essary and sufficient to drive clustering, as inferred from
earlier studies (Chapman et al., 1996; Sugita et al., 1996).
To address this issue, we carried out oligomerization as-
says using the isolated C2 domains of synaptotagmin. Sol-
uble C2A did not bind to immobilized C2A or C2B, and
soluble C2B did not bind to immobilized C2A (Fig. 2).
However, in the presence of Ca
 
2
 
1
 
, soluble C2B bound to
immobilized C2B (Fig. 2). These data demonstrate that
C2B is necessary and sufficient to drive synaptotagmin oli-
gomerization. Furthermore, C2B functions as a Ca
 
2
 
1
 
-sens-
ing module.
The putative Ca
 
2
 
1
 
 ligands within the C2B domain of
synaptotagmin are indicated in the model shown in Fig. 3
A. To assess the function of these putative ligands, they
were neutralized by substitution with asparagine residues
either individually or in combination, and the resulting
mutant proteins were assayed for oligomerization activity
as described in Fig. 1 B. As a negative control, the
K326,327A mutant was assayed and failed to oligomerize
(Fig. 3, B and C), which is consistent with our previous re-
port (Chapman et al., 1998). As an additional control, the
D230,232N mutant, which abolishes Ca21-triggered inter-
actions of synaptotagmin with anionic phospholipids and
the SNARE complex (Bai et al., 2000), failed to inhibit the
Ca21-triggered clustering activity (Fig. 3, B and C). These
data are consistent with Fig. 2, demonstrating that the C2B
domain is both necessary and sufficient for Ca21-triggered
oligomerization. Surprisingly, individual substitutions of
the putative Ca21 ligands within C2B had little effect on
clustering activity. Rather, a slight trend toward constitu-
tive self-association was observed among the point mu-
tants (Fig. 3 C). Moreover, simultaneous neutralization of
two (D363,365N) or four (D303,309,363,365N) of the five
acidic Ca21 ligands clearly resulted in Ca21-independent
constitutive clustering activity (Fig. 3, B and C). These
data provide strong evidence that the conserved putative
Ca21 ligands are functional and regulate synaptotagmin
clustering. The conversion from regulated to constitutive
clustering activity is addressed in the Discussion.
The inability of single point mutations to significantly
disrupt Ca21-triggered clustering activity suggests that
C2B binds multiple Ca21 ions in a redundant manner. Loss
of individual sites are tolerated since other sites remain in-
tact. This is in striking contrast to the C2A domain of syn-
aptotagmin, in which each of the Ca21 ligands are essential
for binding to anionic phospholipids (Zhang et al., 1998;
Bai et al., 2000). The interaction of synaptotagmin with
SNAREs exhibits an intermediate dependence on Ca21
ligands within C2A: some mutations are tolerated, whereas
other mutations have strong disruptive effects (Chapman
et al., 1995; Bai et al., 2000). There appear to be multiple
modes by which Ca21 binding can regulate the interactions
of the C2 domains of synaptotagmin with effector mole-
cules.
Ca21 Drives a Conformational Change in the C2B 
Domain of Synaptotagmin
The experiments described above provide strong evidence
that the C2B domain of synaptotagmin binds Ca21, which
drives clustering of the protein. We next sought to deter-
mine whether clustering is achieved via a Ca21-induced
conformational change in C2B. Ca21-triggered polymer-
ization of synaptotagmin (secondary to oligomerization)
made a number of biophysical methods (NMR, CD, fluo-
rescence measurements, etc.) inapplicable. To circumvent
this problem, we applied a limited proteolysis approach to
detect Ca21-driven conformational changes in the domain.
For these experiments, the C2B domain of synaptotag-
min Ib was immobilized as a GST fusion protein. In addi-
tion, the quadruple Ca21 ligand mutant version of C2B,
D303,309,363,365N, as well as the K326,327A mutant that
Figure 2. The C2B domain of synaptotagmin is necessary and
sufficient for Ca21-triggered synaptotagmin oligomerization.
C2A–C2A, C2A–C2B, and C2B–C2B interactions were assayed
by incubating soluble isolated C2 domains (8 mM protein) with
immobilized GST–C2 domain fusion proteins (10 mg) as de-
scribed in Fig. 1 B. Samples were subjected to SDS-PAGE, and
proteins were visualized by staining with Coomassie blue.Desai et al. C2B Domain of Synaptotagmin Is a Ca21 Sensor 1129
fails to oligomerize (Fig. 3 B; Chapman et al., 1998), were
analyzed in parallel. Fusion proteins were incubated with
increasing concentrations of trypsin or chymotrypsin in
the presence of EGTA or Ca21, and the proteolysis pat-
terns were analyzed by SDS-PAGE. As shown in Fig. 4 A,
the degradation patterns of wild-type C2B in EGTA ver-
sus Ca21 were distinct, suggesting that C2B undergoes a
conformational change upon binding Ca21. With both pro-
teases, a protease resistant fragment accumulated in the
presence of Ca21, suggesting that Ca21 binds to and stabi-
lizes the domain, which is analogous to the limited proteol-
ysis data using C2A as a substrate (Davletov and Südhof,
1994). This differential proteolysis pattern was not observed
using the Ca21 ligand mutant C2B domain as a substrate,
providing further evidence that these acidic residues
(D303,309,363,365N) constitute functional Ca21 ligands
(Fig. 4 A). Interestingly, the K326,327A mutant that fails
to oligomerize is still capable of sensing Ca21 (Fig. 4 A,
bottom). Because C2 domains bind Ca21 via a bipartite
motif in which distal regions of the domain must come to-
gether via folding into a compact tertiary structure, this
finding strongly indicated that the K326,327A mutant is
correctly folded. The loss of oligomerization activity of
this mutant (Chapman et al., 1998; Fig. 3 B) is not due to a
loss of Ca21 sensitivity, but rather is likely due to perturba-
tion of its oligomerization interface.
We exploited the Ca21-dependent accumulation of a
protease-protected fragment to determine the Ca21 de-
pendence of this conformational change. Limited proteol-
ysis was carried out at a fixed protease concentration, and
the [Ca21]free was varied. The appearance of the protected
fragment was quantified by densitometry and is plotted in
Fig. 4 B. The [Ca21]1/2 was z62 6 20 mM, which is consis-
tent with the Ca21 dependence for exocytosis (Heidel-
berger et al., 1994). This value is similar to the [Ca21]1/2 for
the interaction of the C2A domain of synaptotagmin I
with anionic phospholipids (Davis et al., 1999). We note
that previous measurements of the Ca21 dependence for
synaptotagmin clustering are highly dependent on the
methods and conditions in which oligomerization was
measured (Chapman et al., 1996; Sugita et al., 1996; Os-
borne et al., 1999). While the limited proteolysis technique
employed here may only report a subset of conformational
changes, this assay system has the advantage that it cir-
cumvents the need to carry out the wash steps employed in
C2B-synaptotagmin pull-down assays and, therefore, ac-
curately reports the Ca21 requirement for a conforma-
tional change within C2B.
We also compared the proteolysis patterns of the C2B
domains of synaptotagmins V–VIII. As shown in Fig. 4 C,
Ca21 drove a conformational change in synaptotagmins V
and VI, suggesting that the C2B domains of multiple syn-
aptotagmin isoforms can sense Ca21. The proteolysis pat-
terns of the C2B domains of synaptotagmins VII and VIII
were not influenced by Ca21, indicating that these domains
either do not sense Ca21, or Ca21-driven conformational
Figure 3. Effects of putative
Ca21 ligand mutations on
Ca21-triggered synaptotag-
min oligomerization. (A)
Schematic diagram of puta-
tive Ca21 ligands within the
C2B domain of synaptotag-
min I. This model is based on
structural studies of a variety
of C2 domains (Sutton and
Sprang, 1995; Sutton et al.,
1995; Grobler et al., 1996;
Perisic et al., 1998; Ubach et
al., 1998a,b) and alignments
between the C2A and C2B
domains of synaptotagmin.
(B) Wild-type (WT) and the
indicated synaptotagmin Ib
point mutants were analyzed
for Ca21-triggered oligomer-
ization activity as described
in Fig. 1 B. Neutralization of
the putative Ca21 ligands re-
sults in an increase in the
Ca21-independent compo-
nent of binding. This effect is
most marked for the qua-
druple Ca21 ligand mutant
D303,309,363,365N, which oligomerizes constitutively. As a negative control, the ability of the K326,327A mutant was assayed in paral-
lel and, consistent with our previous report (Chapman et al., 1998), failed to oligomerize in response to Ca21. As a further control, the
D230,232N mutant, which fails to bind Ca21 via its C2A domain, was also assayed and found to exhibit Ca21-triggered oligomerization
activity. (C) Binding assays from the representative experiment shown in B were quantified by densitometry and plotted. The level of
binding was normalized to the pixel intensity of the soluble protein in the two left lanes (corresponding to 7% if the ligand used in the
binding assay).The Journal of Cell Biology, Volume 150, 2000 1130
changes within these particular domains cannot be de-
tected using this method. We note that the C2B domain of
synaptotagmin VIII lacks three of the five acidic Ca21
ligands (Fig. 1 A) and would not be expected to bind Ca21
(Fig. 4 C). In contrast, synaptotagmin VII possesses each
of the conserved Ca21 ligands. Further studies, using a dif-
ferent approach, are required to determine whether the
C2B domain of synaptotagmin VII can sense Ca21 and
change conformation.
Finally, as a further control to determine the effects of
the D303,309,363,365N and K326,327A mutations on the
structure of synaptotagmin, we assayed for the interaction
of these mutants with effectors that bind to the C2B do-
main. As shown in Fig. 4 D, the D303,309,363,365N mu-
tant exhibited undiminished ability to bind native synap-
totagmin in response to Ca21. This result is not surprising
since the oligomerization activity of native synaptotagmin
is off in the absence of Ca21 such that the native protein
cannot bind the constitutively activated immobilized pro-
tein. Upon binding Ca21, the native protein is activated
and binds to the oligomerization competent (albeit consti-
tutively) immobilized mutant protein. We observed that
AP-2 and synprint bound to the quadruple Ca21 ligand
mutant to the same extent as the wild-type protein, indi-
cating that the mutant protein is correctly folded. In con-
trast to a previous report (Schiavo et al., 1995), we did not
detect binding of b-SNAP to any of our immobilized syn-
aptotagmin constructs. Consistent with our previous re-
port, the K326,327A exhibited markedly reduced binding
to native synaptotagmin, AP-2, and synprint. However,
this domain appears to be correctly folded, since, as de-
scribed above, this mutant still functions as a Ca21 sensor.
Figure 4. Ca21 drives a con-
formational change in the
C2B domain of synaptotag-
min. (A) The C2B domain of
synaptotagmin Ib was immo-
bilized as a GST fusion pro-
tein subjected to limited pro-
teolysis in the presence of
Ca21 or EGTA. Two mutant
versions of C2B were ana-
lyzed in parallel. In one mu-
tant, four of the five acidic
Ca21 ligands were neutral-
ized by substitution with as-
paragine residues (D303,309,
363,365N) resulting in consti-
tutively oligomerized synap-
totagmin (Fig. 3 B). In the
other mutant, lysine residues
326 and 327 were substituted
with alanine residues, which
abolishes clustering activity
(Fig. 3 B; Chapman et al.,
1998). 20 mg of wild-type
GST-C2B (GST-C2Bwt),
Ca21 ligand mutant (GST-
C2BD303,309,363,365N), or the
lysine mutant Gst-
C2BK326,327A)were incubated
in TBS with the indicated
concentration of trypsin or
chymotrypsin for 60 min at
room temperature in either 1 mM Ca21 (1Ca21) or 2 mM EGTA (2Ca21). Samples were boiled in SDS sample buffer and analyzed by
SDS-PAGE and staining with Coomassie blue. (B) The Ca21 dependence for Ca21-driven conformational changes in C2B was assayed
by monitoring the formation of a chymotrypsin-protected fragment that accumulates in the presence of Ca21 (as indicated by the aster-
isk in A, middle panel). The generation of this fragment was assayed as a function of [Ca21]free, quantified by densitometry and plotted.
The EC50 5 62 6 20 mM (n 5 3). Representative data are shown and plotted. (C) Limited proteolysis of the C2B domains of synap-
totagmins V–VIII. Assays were carried out, as described in A, using 300 ng/ml chymotrypsin. (D) Effector interactions of synaptotagmin
C2B mutants. 30 mg of GST alone, GST fused to the cytoplasmic domains of wild-type (wt), the K326,327A, or the D303,309,363,365N
synaptotagmin Ib, were immobilized onto 20 ml glutathione–Sepharose. To assay for native synaptotagmin I, AP-2, and b-SNAP bind-
ing, beads were incubated for 2 h with 1 ml (1 mg/ml) rat brain detergent extract in the presence of 2 mM EGTA (2) or 1 mM Ca21 (1)
in HBS. Beads were washed three times and bound proteins were eluted by boiling in SDS sample buffer. Samples were resolved by
SDS-PAGE and bound proteins were analyzed by immunoblotting. Immunoreactive bands were visualized using enhanced chemilumi-
nescence. 10 mg of the extract (total) and 15% of the bound material were loaded onto the gel. For synprint binding assays, 20 mg of the
immobilized proteins were incubated with 0.5 mM recombinant synprint in 200 ml of HBS with 0.1% Triton X-100 in the presence of ei-
ther 2 mM EGTA (2) or 1 mM Ca21 (1). Samples were processed as described above and bound synprint was detected using and anti–
T7-tag monoclonal antibody (Novagen) and enhanced chemiluminescence. 3% of the total binding reaction (total) and 12% of the
bound material were loaded onto the gel.Desai et al. C2B Domain of Synaptotagmin Is a Ca21 Sensor 1131
Furthermore, this mutant is capable of efficiently coimmu-
noprecipitating with t-SNAREs and SNARE complexes
(data not shown), an interaction that requires the C2B do-
main of the protein (Chapman et al., 1996; Davis et al.,
1999). Finally the circular dichroism spectra of the wild-
type and K326,327A mutant are identical (data not shown).
Thus, both mutants appear to be correctly folded.
Ca21-triggered Synaptotagmin Oligomerization Is a 
Conserved Property among Different
Synaptotagmin Isoforms
A key issue raised by the data presented above is whether
the clustering activity of synaptotagmin Ib functions in ex-
citation-secretion coupling. First, we addressed the ques-
tion of whether synaptotagmin Ia or Ib is typical of the
synaptotagmin family of proteins by examining the homo-
and hetero-oligomerization activity of synaptotagmins
I–VIII using the approach described in Fig. 1 B. Ca21-trig-
gered homo- and hetero-oligomerization is a highly con-
served function of nearly all synaptotagmins (Fig. 5). No-
table exceptions appear to be synaptotagmin VII and VIII
(note, because of proteolysis problems that obscured the
region of interest on the gels, some of the data concerning
these isoforms was omitted from Fig. 5; these data are
summarized here). Synaptotagmin VIII lacks three of the
five acidic Ca21 ligands (Fig. 1 A) and cannot homo-oligo-
merize in response to Ca21. However, immobilized synap-
totagmin VIII can clearly serve as an acceptor for binding
other synaptotagmin isoforms, as indicated by the robust
binding of soluble synaptotagmin III to immobilized syn-
aptotagmin VIII (Fig. 5). Again, these data indicate that
clustering involves the interaction of two distinct sites
on C2B.
The other exception, synaptotagmin VII, efficiently
bound to each of the immobilized synaptotagmin isoforms
tested. However, these interactions are not promoted by
Ca21; in some cases, Ca21 triggered slight decreases in the
level of binding (Fig. 5). As discussed above, the basis for
this unusual behavior is not readily apparent from the pri-
mary structure of the protein. Like synaptotagmin VIII,
immobilized synaptotagmin VII can serve as an acceptor
for the Ca21-dependent binding of soluble synaptotagmin
isoforms. In summary, all synaptotagmin isoforms tested
exhibit some form of homo- and/or hetero-oligomeriza-
tion activity. The conservation of this biochemical function
suggested that it may be tenable to carry out dominant
negative experiments to investigate whether, and at what
stage, synaptotagmin oligomerization functions in regu-
lated exocytosis.
Inhibition of Synaptotagmin Clustering Blocks
Ca21-triggered Exocytosis
A variant PC12 cell line lacking synaptotagmin I exhibits
normal-to-elevated secretory responses (Shoji-Kasai et al.,
1992). However, this cell line expresses numerous other
synaptotagmin isoforms including synaptotagmin III, IV,
and V (Mizuta et al., 1994; Hudson and Birnbaum, 1995;
Vician et al., 1995). Our findings described above, demon-
strating that recombinant synaptotagmin I can homo- and
hetero-oligomerize with synaptotagmins I, III, IV, and V,
suggested that it may be possible to apply a dominant neg-
ative approach, using mechanically permeabilized PC12
cells, to study the function of synaptotagmin clustering in
Ca21-triggered exocytosis.
Secretion from permeable PC12 cells involves two
stages: an ATP- and cytosol-dependent priming stage, fol-
lowed by a Ca21- and cytosol-dependent triggering reac-
tion (Hay and Martin, 1992). We reasoned that recombi-
nant fragments of synaptotagmin would, in the presence of
Ca21, oligomerize with native synaptotagmin in the per-
meable cell preparation, and thereby block native synap-
totagmin oligomerization. If the Ca21-triggered clustering
of native copies of synaptotagmin functions in secretion,
recombinant synaptotagmin should block exocytosis. As
shown in Fig. 6, the cytoplasmic domain of synaptotagmin
Ib (referred to as C2AB in the figure) potently inhibited
exocytosis. To determine whether inhibition was medi-
ated by the Ca21-triggered binding of recombinant C2AB
to native synaptotagmin, we tested the ability of the
K326,327A mutant, which only weakly clusters in response
to Ca21 (Fig. 3 B; Chapman et al., 1998; Davis et al., 1999),
to inhibit exocytosis. As shown in Fig. 6, this mutant is not
an effective inhibitor of secretion. We note that the
K326,327A mutant is able to bind to SNAREs (Chapman
et al., 1998), and this interaction requires both C2A and
C2B (Chapman et al., 1995; Davis et al., 1999). These data
indicate that C2B is not simply misfolded. The K326,327A
mutant is also able to bind anionic phospholipids (Bai et
al., 2000), yet fails to inhibit secretion. The results of these
experiments are consistent with the hypothesis that C2AB
blocks exocytosis via its C2B-mediated clustering activity.
Figure 5. Ca21-triggered homo- and hetero-oligomerization is
conserved among multiple synaptotagmin isoforms. Fusion pro-
teins corresponding to the cytoplasmic domains of synaptotag-
min I–VIII (Li et al., 1995) were immobilized on glutathione-
Sepharose (10 mg protein/assay point) and incubated with soluble
versions of each synaptotagmin (1–2 mM) generated via throm-
bin cleavage of GST fusion proteins. Binding was carried out for
2 h at 48C in 150 ml of TBS plus 0.5% Triton X-100 in either 2
mM EGTA (2) or 1 mM Ca21 (1). Pellets were washed three
times, and bound material was eluted by boiling in SDS-PAGE
sample buffer for 5 min. 25% of the bound material and 7.5% of
the soluble protein was subjected to SDS-PAGE and stained
with Coomassie blue. Due to size considerations and clarity of
presentation, gels were cropped, and only the region containing
soluble synaptotagmin fragments are shown. However, the levels
of immobilized proteins were carefully matched and are not a sig-
nificant source of variability in the efficiency of ligand capture. In
some cases, proteolysis of the immobilized fusion protein ob-
scured the relevant region of the gel; these regions were excluded
from the figure.The Journal of Cell Biology, Volume 150, 2000 1132
To further test this model, we compared the ability of
the isolated C2 domains of synaptotagmin to inhibit re-
lease. As shown in Fig. 6, C2B inhibited release in a man-
ner analogous to C2AB. In contrast, C2A failed to inhibit
secretion. Furthermore, we generated a mutant C2B do-
main harboring the K326,327A mutation, and this version
of C2B failed to cluster (data not shown) and failed to in-
hibit exocytosis (Fig. 6). Finally, we examined the ability
of a mutant C2AB domain, which harbored two muta-
tions, D230,232N, within the C2A domain that abolish
Ca21-triggered C2A–effector interactions (Davis et al.,
1999; Bai et al., 2000). This double mutant retained all of
the inhibitory activity of wild-type C2AB (Fig. 6), despite
the fact that it fails to bind either lipids or SNAREs in re-
sponse to Ca21. Thus, all of the synaptotagmin fragments
that exhibit Ca21-triggered clustering activity are able to
inhibit exocytosis in this assay system, and all fragments
that fail to cluster in response to Ca21 fail to inhibit secre-
tion despite the fact that other effector interactions remain
intact. We also tested the C2A and C2B domains of rab-
philin for inhibitory activity. Neither of the isolated
rabphilin C2 domains bind to synaptotagmin (data not
shown), and neither fragment inhibited secretion (Fig. 6),
further establishing the specificity of the synaptotagmin
C2B domain effect. We have tested additional C2 do-
mains, from other proteins, and observed that some are in-
hibitory in our secretion assay; these C2 domains can also
cluster with synaptotagmin, which is consistent with a
model in which perturbation of native synaptotagmin clus-
tering inhibits exocytosis (data not shown). Clustering may
be a shared biochemical property among C2 domains from
distinct proteins.
To further explore the dominant negative effect of
C2AB, we determined whether inhibition occurs during
the ATP-dependent priming stage or the Ca21-triggered
stage of secretion. If the inhibition of exocytosis is medi-
ated via Ca21-triggered clustering of recombinant synap-
totagmin with the endogenous native protein, the inhibi-
tory effect should be restricted to the Ca21-triggered step
in secretion. Indeed, this was the case; C2AB added during
priming, and then washed out before triggering, has only a
limited effect on release (Fig. 7 A). In contrast, C2AB that
was added during the Ca21-triggered stage resulted in the
potent inhibition of secretion, presumably because Ca21
triggered the oligomerization of recombinant with endog-
enous synaptotagmin (Fig. 7 A). Again, C2A served as a
negative control.
We next sought to address the function of synaptotag-
min oligomerization in exocytosis using an independent
approach. This was achieved by analyzing the effects of
the synprint peptide on secretion. Synprint corresponds
to the II-III loop of N-type Ca21 channels and binds to
t-SNAREs and to synaptotagmin (Kim and Catterall,
1997; Sheng et al., 1997). A critical point is that synprint
binds to synaptotagmin in a Ca21-independent manner
and can block Ca21-triggered synaptotagmin-clustering
(Chapman et al., 1998). Thus, if clustering is critical for
exocytosis, synprint should serve as an effective inhibitor
akin to C2AB and C2B described above. However, in the
case of synprint, the inhibitory effect should be equally ef-
fective during the ATP-dependent priming step (in the ab-
sence of Ca21) as in the Ca21-triggered stage of exocytosis,
again because synprint can bind synaptotagmin equally
well in the presence or absence of Ca21. Congruent with
this model, synprint inhibited exocytosis with equal or
greater activity during the Ca21-independent priming
stage of secretion (Fig. 7 B). These data provide indepen-
dent confirmation that disruption of synaptotagmin oligo-
merization can disrupt Ca21-triggered exocytosis.
We note that a caveat of our inhibition studies is the
ability of recombinant synaptotagmin and synprint to in-
teract with a number of distinct proteins. For example, a
recent study indicated that synprint can inhibit the binding
of synaptotagmin and cysteine string protein to syntaxin
(Wu et al., 1999). However, synprint binds much more
tightly to syntaxin in the presence, rather than the absence
of Ca21 (Kim and Catterall, 1997; Littleton et al., 1998; and
data not shown), yet in our secretion assays, synprint does
not preferentially inhibit release during the triggering
phase when Ca21 is present. Therefore, we view it as un-
likely that synprint exerts its inhibitory effects via binding
to syntaxin.
Figure 6. A dominant negative approach to
study the function of synaptotagmin oligomeriza-
tion in Ca21-triggered exocytosis from permeable
PC12 cells. PC12 cells were loaded with
3[H]norepinephrine (NE) and permeabilized by
passage through a ball homogenizer. Permeable
cells were incubated for 30 min at 308C with ATP
and rat brain cytosol to prime exocytosis. The
cells were washed and incubated with the indi-
cated concentrations of the cytoplasmic domain
of synaptotagmin (C2AB), C2A, C2B, or
K326,327A-substitution mutant versions of
C2AB/C2B, for 45 min on ice. (right) The C2A
and C2B domains of rabphilin were tested as de-
scribed for synaptotagmin. Exocytosis was triggered by incubating with Ca21 (10 mM) plus rat brain cytosol for 3 min at 30°C. Released
3H-NE was quantified by liquid scintillation counting, and is plotted as the percentage of the total 3H-NE content of the cells. Data
shown represent the mean of duplicate determinations, with each duplicate differing by ,5% of the mean value. Oligomerization-com-
petent fragments of synaptotagmin, C2AB, C2B, and C2AB-D230,232N, potently inhibited secretion, whereas nonoligomerizing pro-
teins, C2A and K326,327A mutant versions of C2AB and C2B, failed to inhibit secretion. Neither C2 domain of rabphilin inhibited exo-
cytosis.Desai et al. C2B Domain of Synaptotagmin Is a Ca21 Sensor 1133
Discussion
In this study, we have demonstrated that the C2B domain
of synaptotagmin functions as a Ca21-sensing module.
Ca21 drives a conformational change in the C2B domain
of synaptotagmin I with a [Ca21]1/2 of 62 6 20 mM, similar
to the Ca21 sensitivity of the C2A domain of this isoform
(Davis et al., 1999) and consistent with the Ca21 depen-
dence of exocytosis (Heidelberger et al., 1994). Further-
more, we directly demonstrate that Ca21 triggers the oligo-
merization of the C2B domain of synaptotagmin Ib, and
this property is conserved among multiple isoforms of the
protein. We propose that Ca21 acts by driving a conforma-
tional change that stabilizes the multimeric form of synap-
totagmin. The C2A domain exhibits a similar conforma-
tional change in limited proteolysis experiments (Davletov
and Südhof, 1994). These changes may reflect the move-
ment of charged residues within or near the Ca21-binding
loops (Ubach et al., 1998b; Chae et al., 1998), as indicated
by structural studies of the C2 domain of phospholipase
C-d1 (Grobler et al., 1996). Given the diffusion-limited ki-
netics of the C2 domains of synaptotagmin, these confor-
mational changes are unlikely to involve large-scale struc-
tural rearrangements (Davis et al., 1999). Numerous C2
domains harbor a conserved set of five acidic residues that
function as Ca21 ligands. Via mutagenesis, we sought to
determine whether these residues indeed function as Ca21
ligands within C2B. We observed that the simultaneous
substitution of four of the five putative acidic Ca21 ligands
within C2B inhibited Ca21-driven conformational changes
and converted the domain to a constitutively oligomeriz-
ing form. The basis for this conversion is unclear. How-
ever, structural studies of the C2 domain of phospholipase
C-d1 indicate that these Ca21 ligands participate in in-
tramolecular ionic bonds (Grobler et al., 1996). Binding of
Ca21 to these acidic ligands serves to release positively
charged side chains, resulting in the opening of the Ca21
binding jaws or loops such that they can interact with ef-
fectors. In this model, neutralization of the acidic Ca21
ligands may result in a constitutively activated domain.
Clearly, however, this is not the case with C2A. In C2A,
neutralization of any of the acidic Ca21 ligands abolishes
phospholipid binding activity (Zhang et al., 1998; Bai et
al., 2000). Additional structural studies are required to un-
derstand the differential effects of Ca21 ligand mutations
on C2A– and C2B–effector interactions. Nonetheless, the
effects of the putative Ca21 ligand mutations in C2B, on
both Ca21-driven conformational changes and clustering
activity, demonstrate that these conserved Ca21 ligands
are functional.
To assess the generality of Ca21-triggered clustering ac-
tivity, we assayed homo- and hetero-oligomerization of
synaptotagmins I–VIII and observed that oligomerization
is a highly conserved biochemical property. These findings
made it possible to employ a dominant negative approach
to study the function of synaptotagmin clustering in per-
meable PC12 cells, which harbor multiple synaptotagmin
isoforms. In all cases, fragments of synaptotagmin that
were capable of clustering, in response to Ca21, served as
potent inhibitors of secretion. This inhibitory activity
mapped to the C2B domain of recombinant synaptotag-
min and required the presence of Ca21, presumably to
drive oligomerization with native synaptotagmin within
the permeable cells. The inhibitory activity did not involve
the binding of Ca21 to the C2A domain of the protein,
demonstrating that Ca21-triggered binding to SNAREs or
anionic phospholipids is not required for the inhibition of
secretion observed in our experiments. In contrast, muta-
tions or deletions that block the clustering activity of the
C2B domain abrogated the ability of recombinant C2B to
block exocytosis. 
Finally, the ability of synprint to inhibit exocytosis in our
assay system, when applied at either the priming or trig-
gering stages of secretion, is also consistent with a model
in which Ca21-triggered synaptotagmin clustering is criti-
cal for exocytosis. In this model, the inhibitory effects of
synprint are independent of the stage of secretion because
synprint can bind to synaptotagmin in a Ca21-independent
manner and block clustering. Thus, synprint should be
able to inhibit secretion when used to treat cells during ei-
ther the Ca21-independent (i.e., ATP-dependent priming)
or the Ca21-triggered stage of secretion, as borne out by
the data. Others have reported that synprint has inhibitory
effects on synaptic transmission. It was suggested that inhi-
bition was due to uncoupling syntaxin from Ca21 channels
(Mochida et al., 1996; Rettig et al., 1997). However,
chronic application of synprint (Rettig et al., 1997) can dis-
rupt synaptotagmin–AP-2 interactions (Zhang et al., 1994;
Chapman et al., 1998), resulting in a loss in the total num-
Figure 7. C2AB selectively blocks exocytosis during the Ca21-
triggered stage, whereas synprint can inhibit secretion during the
Ca21-independent priming stage of exocytosis. Exocytosis in per-
meable PC12 cells was primed in 30-min incubations with ATP
and triggered in 3-min incubations with Ca21 as described in Fig.
6. Released 3H-NE was quantified by liquid scintillation counting
and is plotted either as the percentage of the total 3H-NE content
of the cells, or was normalized to the maximal level of release ob-
tained without added inhibitors and plotted as % control. Data
shown represent the mean of duplicate determinations with the
range indicated or within 10% of the mean value. (A, left) C2AB,
or as a control, C2A, at 30 mM was incubated with the permeable
PC12 cells during priming or triggering reactions. To specifically
test for the effects on priming, proteins were present during 30-
min incubations, and the permeable cells were washed before
3-min triggering incubations with Ca21. (A, right) The indicated
concentrations of C2AB were incubated with permeable PC12
cells only during the priming (closed squares) or only during the
triggering (open circles) stages of secretion. (B) The indicated
concentrations of synprint were incubated with permeable PC12
cells during the priming (closed squares) or triggering (open cir-
cles) stages of secretion.The Journal of Cell Biology, Volume 150, 2000 1134
ber of vesicles (Jorgensen et al., 1995). Use of permeable
PC12 cells circumvents a number of these problems since
Ca21-triggered secretion does not depend upon Ca21 chan-
nels nor upon endocytosis.
In an earlier report, a microinjection approach was used
to assess the effects of synaptotagmin fragments on secre-
tion from intact PC12 cells (Elferink et al., 1993). While
C2AB and C2B did not appear to inhibit secretion, it was
noted that these fragments had a tendency to aggregate
and were difficult to quantitatively introduce into cells;
from these studies, the potential ability of C2AB and C2B
to inhibit secretion was not ruled out (Elferink et al.,
1993). The use of permeable PC12 cells overcomes these
difficulties and demonstrates that these fragments indeed
inhibit release. Furthermore, recent experiments from
L.A. Elferink and A.E. Hawley (personal communica-
tion), using viruses to infect PC12 cells, indicate that C2B
is indeed critical for secretion from intact cells. Thus, the
only apparent discrepancy between the initial PC12 cell
microinjection data and the data present in our study is the
inability of C2A to inhibit secretion in our assay system.
One possible explanation is that C2A inhibits an upstream
step in the vesicle trafficking pathway in intact cells (Elf-
erink et al., 1993), which is not recapitulated in the perme-
able cells.
The function of C2B-mediated synaptotagmin clustering
during exocytosis is not clear. We hypothesize that C2B-
mediated oligomerization may drive the assembly of the
fusion machinery into a collar or ringlike fusion pore or
may alter the stability/conformation of a weakly preas-
sembled pore. This hypothesis stems from the observation
that purified SNARE-complexes do not efficiently cluster
into multimeric complexes akin to viral fusion proteins
(Lindau and Almers, 1995; Blumenthal et al., 1996;
Danieli et al. 1996; Fasshauer et al., 1997). Also, a protein
designated EEA1 recently has been reported to cluster
syntaxin-13 into oligomeric structures, and this oligomer-
ization is required for endosomal fusion (McBride et al.,
1999). Indeed, genetic studies indicate that synaptotagmin
functions as a multimeric complex (Littleton et al., 1994).
We speculate that the Ca21-driven clustering activity of
synaptotagmin may regulate the initial Ca21-triggered
opening (Katz, 1969) or subsequent dilation (Fernandez-
Chacon and Alvarez de Toledo, 1995) of the exocytotic fu-
sion pore (Lindau and Almers, 1995).
The oligomerization of synaptotagmin may have other
functions as well. In a previous report, we demonstrated
that a seizure-induced isoform of synaptotagmin, IV, can
form hetero-oligomers with synaptotagmin I. Upregula-
tion of synaptotagmin IV reduces synaptic transmission,
potentially by hetero-oligomerizing to form synaptotag-
min clusters with hybrid properties (Littleton et al., 1999).
Hetero-oligomerization of synaptotagmins with unique
Ca21-sensing properties may provide a means to modulate
release probability and, thus, modulate synaptic function.
In summary, we have identified a key function for the
C2B domain of synaptotagmin in excitation-secretion
coupling: C2B udergoes Ca21-driven conformational
changes and assembles synaptotagmin into oligomers. In
this light, we reiterate that a point mutation within this
domain increases the Ca21 requirement for secretion
(Littleton et al., 1994). Future studies will determine
whether this phenotype results from an impaired ability
of C2B to function as a Ca21-sensing oligomerization
module.
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